Skip to Main Content Area
accueil
Contact
Who are we ?
Associative project
Status
History
History
AirHelp
Respiratory physiotherapy
Meveol
New therapeutic way
Scientific data
Publications
Publications Meveol
Meveol Resultats
Mechanisms Mévéol
The cystic fibrosis
A genetic disease
Mechanisms and symptoms
Key figures
Meveol Project
Home
»
Actualités
11/17/2011
Donner sa chance à l'innovation
11/29/2010
New Site, help us improve.
06/22/2010
Meveol vs Mycobacterium abscessus
06/22/2010
Mycobacterium abscessus vs. Meveol
06/22/2010
Meveol vs Mycobacterium abscessus
06/20/2010
Meveol vs Mycobacterium abscessus
04/09/2010
Cystic supports the program Meveol
04/09/2010
Mucovie soutient le programme Meveol
12/09/2009
Meveol : orphan drug status granted by the FDA for the treatment of cystic fibrosis.
12/09/2009
Meveol: statut de médicament orphelin accordé par la FDA pour le traitement de la fibrose kystique.
10/17/2009
Jean Paul Perraudin Meveol present at Beijing, 9th World Congress Lactoferrin
10/17/2009
Jean Paul Perraudin presents Meveol at Beijing, 9th Lactoferrin World Congress
09/03/2009
Meveol is designated orphan medicinal product in Europe for the treatment of cystic fibrosis.
09/03/2009
Designated orphan medicinal Meveol IS product in Europe for the Treatment of cystic fibrosis.
Happy New Year 2010
Howard Hinton Sevens
Event planner first news
Bonne année 2010
Howard Hinton Sevens
Meveol vs Mycobacterium abscessus
Feedback
If you experience a bug or would like to see an addition on the current page, feel free to leave us a message.
Message:
*